Cargando…

Cellular phenotypic transitions in diabetic nephropathy: An update

Diabetic nephropathy (DN) is a major cause of morbidity and mortality in diabetes and is the most common cause of end stage renal disease (ESRD). Renal fibrosis is the final pathological change in DN. It is widely believed that cellular phenotypic switching is the cause of renal fibrosis in diabetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yiling, Lin, Ji-Hong, Hammes, Hans-Peter, Zhang, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666367/
https://www.ncbi.nlm.nih.gov/pubmed/36408221
http://dx.doi.org/10.3389/fphar.2022.1038073
_version_ 1784831489442054144
author Cao, Yiling
Lin, Ji-Hong
Hammes, Hans-Peter
Zhang, Chun
author_facet Cao, Yiling
Lin, Ji-Hong
Hammes, Hans-Peter
Zhang, Chun
author_sort Cao, Yiling
collection PubMed
description Diabetic nephropathy (DN) is a major cause of morbidity and mortality in diabetes and is the most common cause of end stage renal disease (ESRD). Renal fibrosis is the final pathological change in DN. It is widely believed that cellular phenotypic switching is the cause of renal fibrosis in diabetic nephropathy. Several types of kidney cells undergo activation and differentiation and become reprogrammed to express markers of mesenchymal cells or podocyte-like cells. However, the development of targeted therapy for DN has not yet been identified. Here, we discussed the pathophysiologic changes of DN and delineated the possible origins that contribute to myofibroblasts and podocytes through phenotypic transitions. We also highlight the molecular signaling pathways involved in the phenotypic transition, which would provide valuable information for the activation of phenotypic switching and designing effective therapies for DN.
format Online
Article
Text
id pubmed-9666367
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96663672022-11-17 Cellular phenotypic transitions in diabetic nephropathy: An update Cao, Yiling Lin, Ji-Hong Hammes, Hans-Peter Zhang, Chun Front Pharmacol Pharmacology Diabetic nephropathy (DN) is a major cause of morbidity and mortality in diabetes and is the most common cause of end stage renal disease (ESRD). Renal fibrosis is the final pathological change in DN. It is widely believed that cellular phenotypic switching is the cause of renal fibrosis in diabetic nephropathy. Several types of kidney cells undergo activation and differentiation and become reprogrammed to express markers of mesenchymal cells or podocyte-like cells. However, the development of targeted therapy for DN has not yet been identified. Here, we discussed the pathophysiologic changes of DN and delineated the possible origins that contribute to myofibroblasts and podocytes through phenotypic transitions. We also highlight the molecular signaling pathways involved in the phenotypic transition, which would provide valuable information for the activation of phenotypic switching and designing effective therapies for DN. Frontiers Media S.A. 2022-11-02 /pmc/articles/PMC9666367/ /pubmed/36408221 http://dx.doi.org/10.3389/fphar.2022.1038073 Text en Copyright © 2022 Cao, Lin, Hammes and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Cao, Yiling
Lin, Ji-Hong
Hammes, Hans-Peter
Zhang, Chun
Cellular phenotypic transitions in diabetic nephropathy: An update
title Cellular phenotypic transitions in diabetic nephropathy: An update
title_full Cellular phenotypic transitions in diabetic nephropathy: An update
title_fullStr Cellular phenotypic transitions in diabetic nephropathy: An update
title_full_unstemmed Cellular phenotypic transitions in diabetic nephropathy: An update
title_short Cellular phenotypic transitions in diabetic nephropathy: An update
title_sort cellular phenotypic transitions in diabetic nephropathy: an update
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666367/
https://www.ncbi.nlm.nih.gov/pubmed/36408221
http://dx.doi.org/10.3389/fphar.2022.1038073
work_keys_str_mv AT caoyiling cellularphenotypictransitionsindiabeticnephropathyanupdate
AT linjihong cellularphenotypictransitionsindiabeticnephropathyanupdate
AT hammeshanspeter cellularphenotypictransitionsindiabeticnephropathyanupdate
AT zhangchun cellularphenotypictransitionsindiabeticnephropathyanupdate